On the other hand, B7-H3 is broadly expressed in sarcomas and a recent study showed that B7-H3 CAR-T cells mediate significant antitumor activity in xenograft models, causing regression of solid tumors including osteosarcoma, medulloblastoma, and Ewing sarcoma [49]. This evidence concerns the gene CD276 and medulloblastoma.